Specifically, we utilized a genetically engineered mouse model (GEMM) harboring a pancreas specific Kras mutation (KrasG12D; pdx1-Cre mice) and treated these animals with caerulein, a well-established inducer of pancreatic inflammation [22, 30, 34]. This evidence concerns the gene KRAS and inflammatory response.